User profiles for Camilla Bjørn Jensen

camilla bjoern jensen

phd-studerende, institut for sygdomsforebyggelse
Verified email at regionh.dk
Cited by 1656

[HTML][HTML] Development and validation of a vitamin D status prediction model in Danish pregnant women: a study of the Danish National Birth Cohort

C Bjørn Jensen, AL Thorne-Lyman, L Vadgård Hansen… - PloS one, 2013 - journals.plos.org
Vitamin D has been hypothesized to reduce risk of pregnancy complications such as
preeclampsia, gestational diabetes mellitus, and preterm delivery. However, many of these …

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD …

…, CM Rasmussen, CB Jensen… - BMJ open …, 2019 - bmjopenrespres.bmj.com
Introduction A large group of patients with chronic obstructive pulmonary disease (COPD)
are exposed to an overload of oral corticosteroids (OCS) due to repeated exacerbations. This …

Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two …

RC Ungaro, BN Limketkai, CB Jensen, KH Allin… - Gut, 2019 - gut.bmj.com
Objective The benefit of continuing 5-aminosalicylate (5-ASA) in patients with ulcerative
colitis (UC) who initiate anti-tumour necrosis factor-alpha (anti-TNF) biologics is unknown. We …

Elevated blood eosinophils in acute COPD exacerbations: better short-and long-term prognosis

…, J Janner, MN Petersen, CB Jensen… - European Clinical …, 2020 - Taylor & Francis
Background Elevated eosinophils in COPD is recognized as a potential risk factor for
exacerbations, but the prognostic role of elevated eosinophils during exacerbations of COPD is …

Stopping mesalamine therapy in patients with Crohn's disease starting biologic therapy does not increase risk of adverse outcomes

RC Ungaro, BN Limketkai, CB Jensen, C Yzet… - Clinical …, 2020 - Elsevier
Background & Aims Little is known about the effects of discontinuing mesalamine therapy for
patients with Crohn’s disease (CD) who initiate therapy with an anti–tumor necrosis factor (…

Comparison of birth weight between school health records and medical birth records in Denmark: determinants of discrepancies

CB Jensen, M Gamborg, B Heitmann, TIA Sørensen… - BMJ open, 2015 - bmjopen.bmj.com
Objective To compare reported birth weight (BW) information in school health records with
BW from medical birth records, and to investigate if maternal and offspring characteristics …

Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: a nationwide Danish cohort study

…, KH Allin, J Burisch, CB Jensen… - United European …, 2020 - journals.sagepub.com
Background Thiopurine and allopurinol in combination are associated with clinical remission
in inflammatory bowel diseases but their influence on subsequent outcomes is unclear. We …

FeNO-based asthma management results in faster improvement of airway hyperresponsiveness

…, AS Homøe, H Meteran, CB Jensen… - ERJ Open …, 2018 - Eur Respiratory Soc
Asthma is characterised by inflammation and respiratory symptoms. Current asthma treatment
is based on severity of asthma symptoms only. Exhaled nitric oxide fraction (F eNO ) is not …

Drug utilization of biologic therapy in Crohn's disease and ulcerative colitis: a population-based Danish cohort study 2015–2020

KJ Jensen, CB Jensen, C Wennerström… - Scandinavian Journal …, 2023 - Taylor & Francis
Objective The aim of the study was to characterize the drug utilization and switch patterns of
biological treatment of ulcerative colitis (UC) and Crohn’s disease (CD). Methods Using …

[HTML][HTML] Monitoring and treatment of hypercholesterolemia after an atherosclerotic cardiovascular disease event in Denmark from 2015 to 2020

…, S Hansen, RH Olsen, J Petersen, CB Jensen - International Journal of …, 2024 - Elsevier
Background and Aims. Lowering the blood concentration of low-density lipoprotein
cholesterol (LDL-C), is a cornerstone in preventing atherosclerotic cardiovascular disease (ASCVD). …